13F HOLDINGS REPORT
DCVC Opportunity Fund II GP, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001104659-25-048969
Total Value
$81.5M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Rocket Lab USA, Inc. | RKLB | 3,388,249 | $60.6M | 74.35% |
| 2 | Recursion Pharmaceuticals, Inc. | RXRX | 3,951,141 | $20.9M | 25.65% |